Sample Set Annotation Tool: Bordet Radcliffe NUH dataset

Study Design
Assay
Sample Info
Files
Info
Samples
Group Sets
Analysis

Purpose

This study aimed to facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes.

Hypothesis

Investigation of the biological origins of coordinately expressed genes in breast cancer could clarify the relationship between prognostic gene signatures and tumor pathobiology.

Experimental Design

This dataset consists of breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore). The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Experimental Variables

Controls

Methods

Breast tumor samples were profiled on the Affymetrix U133A platform.

Additional Information

Nagalla, Srikanth, Jeff W. Chou, Mark C. Willingham, Jimmy Ruiz, James P. Vaughn, Purnima Dubey, Timothy L. Lash, et al. “Interactions between Immunity, Proliferation and Molecular Subtype in Breast Cancer Prognosis.” Genome Biology 14, no. 4 (April 29, 2013): R34. doi:10.1186/gb-2013-14-4-r34.

Expected Samples:

139 Samples Loaded: 139

Species

Human (Homo sapiens)

Sample Source

Institute Jules Bordet, Brussels, Belgium , John Radcliffe Hospital, Oxford, UK , National University Hospital, Singapore , Nagalla 2013 , Breast Cancer Tissue

Disease

Mixed Breast Cancer Types

Treatment Protocol

Growth Protocol

Extraction Protocol

Storage Conditions

Sample Set Spreadsheet

Please log in in order to upload files.

Samples Preview

Sample ID	series	IMS	IBS	IDS	ICR
GSM1100037	NA	LumA	IBD	WID	ICR4
GSM1100038	NA	LumB	IBE	WID	ICR3
GSM1100039	NA	Normal	IBE	NA	ICR1
GSM1100040	NA	LumA	IBD	PID	ICR1
GSM1100041	NA	LumA	IBD	PID	ICR2

Please log in in order to upload files.

File
GSE45255_appended.meta.data_v1.csv Sample Set Spreadsheet

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID	Series	IMS	IBS	IDS	ICR	HER2 Status	Array Sample ID	Sample Title	DMFS 10Y EVENT	DMFS 10Y TIME	Disease Free Survival Event	Distant Met Free Survival Event	Age At Initial Pathologic Diagnosis	Lymph Node Status	ER Status	PR Status	Histology Differentiation Grade	Tumor Size Cm	Pathology T Stage	Disease Free Survival Years	Distant Met Free Survival Years	Disease Specific Survival Years	Treatment Adjuvant	Characteristics Endocrine?	Chemo?	Breast Cancer Cause Of Death	Histologic Diagnosis	Type Treatment
GSM1100037	NA	LumA	IBD	WID	ICR4	HER2-	400003289	NUH.BT009	DistantMetastasisFree	6.17	DiseaseFree	DistantMetastasisFree	41	LN-	ER+	PR+	G2	2	T1c	6.17	6.17	6.17	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100038	NA	LumB	IBE	WID	ICR3	HER2+	400003290	NUH.BT014	DistantMetastasis	1.13	Recurred/Progressed	DistantMetastasis	62	LN+	ER-	PR-	G2	3	T2	1.13	1.13	1.13	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100039	NA	Normal	IBE	NA	ICR1	HER2-	400003291	NUH.BT018	DistantMetastasisFree	4.29	DiseaseFree	DistantMetastasisFree	69	LN-	ER+	PR+	G2	3	T2	4.29	4.29	4.29	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100040	NA	LumA	IBD	PID	ICR1	HER2-	400003292	NUH.BT019	DistantMetastasisFree	5.88	DiseaseFree	DistantMetastasisFree	69	LN-	ER+	PR+	G2	3.5	T2	5.88	5.88	6.04	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100041	NA	LumA	IBD	PID	ICR2	HER2+	400003293	NUH.BT022	DistantMetastasisFree	2.63	DiseaseFree	DistantMetastasisFree	40	LN-	ER+	PR+	G2	2.5	T2	2.63	2.63	2.63	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100042	NA	Normal	IBE	NA	ICR2	HER2+	400003294	NUH.BT023	DistantMetastasisFree	6.25	DiseaseFree	DistantMetastasisFree	69	LN-	ER+	PR-	G2	2.5	T2	6.25	6.25	6.25	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100043	NA	LumB	IBD	WID	ICR3	HER2+	400003295	NUH.BT029	DistantMetastasis	2	Recurred/Progressed	DistantMetastasis	54	LN+	ER-	PR-	G2	6	T3/T4	2	2	2.25	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100044	NA	Normal	IBE	NA	ICR2	HER2+	400003296	NUH.BT031	DistantMetastasisFree	5.63	DiseaseFree	DistantMetastasisFree	48	LN-	ER+	PR+	G2	2	T1c	5.63	5.63	5.63	NA	NA	NA	0	invasive ductal carcinoma	NA
GSM1100045	NA	Normal	IBE	NA	ICR3	HER2+	400003297	NUH.BT035	DistantMetastasisFree	4.04	DiseaseFree	DistantMetastasisFree	46	LN-	ER-	PR-	G2	1.5	T1c	4.04	4.04	4.08	0	no	no	0	invasive ductal carcinoma	none
GSM1100046	NA	NA	IBE	NA	ICR2	HER2-	400003298	NUH.BT042	DistantMetastasisFree	6	DiseaseFree	DistantMetastasisFree	53	LN-	ER+	PR-	G2	1.8	T1c	6	6	6	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100047	NA	ClaudinLow	IBD	WID	ICR2	HER2-	400003299	NUH.BT046	DistantMetastasisFree	5.79	DiseaseFree	DistantMetastasisFree	52	LN-	ER+	PR+	G2	1.8	T1c	5.79	5.79	5.79	1	no	yes	0	invasive ductal carcinoma	CMF
GSM1100048	NA	LumA	IBD	PID	ICR1	HER2-	400003300	NUH.BT047	DistantMetastasisFree	5.83	DiseaseFree	DistantMetastasisFree	50	LN+	ER-	PR+	G2	2.5	T2	5.83	5.83	5.83	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100049	NA	LumB	IBD	WID	ICR2	HER2-	400003301	NUH.BT049	DistantMetastasisFree	5.75	DiseaseFree	DistantMetastasisFree	53	LN+	ER-	PR+	G2	2.2	T2	5.75	5.75	5.92	1	no	yes	0	invasive ductal carcinoma	CMF
GSM1100050	NA	Normal	IBE	NA	ICR3	HER2+	400003302	NUH.BT054	DistantMetastasisFree	5.58	DiseaseFree	DistantMetastasisFree	77	LN-	ER+	PR-	G2	3.5	T2	5.58	5.58	5.58	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100051	NA	Her2	IBD	PID	ICR2	HER2-	400003303	NUH.BT055	DistantMetastasisFree	6.33	DiseaseFree	DistantMetastasisFree	60	LN-	ER+	PR+	G2	2	T1c	6.33	6.33	6.33	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100052	NA	NA	NA	NA	NA	HER2+	400003304	NUH.BT061	NA	NA	NA	NA	51	LN+	ER+	PR-	G2	2.5	T2	NA	NA	NA	1	yes	yes	NA	invasive ductal carcinoma	Tam+ACx8;taxol
GSM1100053	NA	Basal	IBD	WID	ICR2	HER2-	400003305	NUH.BT067	DistantMetastasisFree	5	DiseaseFree	DistantMetastasisFree	69	LN+	ER+	PR+	G2	2.5	T2	5	5	5	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100054	NA	Her2	IBD	WID	ICR2	HER2+	400003306	NUH.BT068	DistantMetastasisFree	5.25	DiseaseFree	DistantMetastasisFree	49	LN+	ER+	PR+	G2	2.3	T2	5.25	5.25	5.25	1	yes	yes	0	invasive ductal carcinoma	Tam+CAFx6 cycles
GSM1100055	NA	Her2	IBD	PID	ICR1	HER2-	400003307	NUH.BT070	DistantMetastasis	0.04	Recurred/Progressed	DistantMetastasis	48	LN-	ER+	PR-	G2	1.5	T1c	0.04	0.04	3.08	1	no	yes	1	invasive lobular carcinoma	anastrozole;taxol
GSM1100056	NA	LumB	IBD	FID	ICR4	HER2+	400003308	NUH.BT074	DistantMetastasisFree	0.67	Recurred/Progressed	DistantMetastasisFree	75	LN+	ER-	PR+	G2	4	T2	0.92	0.67	5.42	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100057	NA	Her2	IBD	FID	ICR2	HER2+	400003309	NUH.BT078	DistantMetastasis	2.83	Recurred/Progressed	DistantMetastasis	67	LN-	ER-	PR-	G2	2.5	T2	2.83	2.83	2.83	0	no	no	0	invasive ductal carcinoma	none
GSM1100058	NA	Her2	IBE	FID	ICR4	HER2-	400003310	NUH.BT083	DistantMetastasisFree	0.67	Recurred/Progressed	DistantMetastasisFree	55	LN-	ER+	PR+	G2	1.5	T1c	1.25	0.67	4.58	0	no	no	0	invasive ductal carcinoma	none
GSM1100059	NA	Basal	IBE	PID	ICR4	HER2-	400003311	NUH.BT086	DistantMetastasisFree	4.67	DiseaseFree	DistantMetastasisFree	35	LN-	ER-	PR+	G2	4	T2	4.67	4.67	4.67	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100060	NA	Basal	IBE	FID	ICR4	HER2+	400003312	NUH.BT087	DistantMetastasisFree	5.67	DiseaseFree	DistantMetastasisFree	46	LN+	ER+	PR+	G2	3	T2	5.67	5.67	5.67	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100061	NA	Basal	IBE	FID	ICR4	HER2-	400003313	NUH.BT088	DistantMetastasisFree	4.67	DiseaseFree	DistantMetastasisFree	44	LN-	ER+	PR+	G2	3.5	T2	4.67	4.67	4.67	1	no	yes	0	invasive ductal carcinoma	CMF
GSM1100062	NA	ClaudinLow	IBD	PID	ICR1	HER2-	400003314	NUH.BT090	DistantMetastasisFree	5.17	DiseaseFree	DistantMetastasisFree	40	LN+	ER+	PR+	G2	2.3	T2	5.17	5.17	5.17	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100063	NA	LumB	IBD	PID	ICR1	HER2+	400003315	NUH.BT093	DistantMetastasisFree	4.75	DiseaseFree	DistantMetastasisFree	57	LN-	ER+	PR+	G2	2.1	T2	4.75	4.75	4.75	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100064	NA	LumB	IBD	PID	ICR1	HER2-	400003316	NUH.BT094	DistantMetastasisFree	4.92	DiseaseFree	DistantMetastasisFree	55	LN+	ER+	PR+	G2	1.9	T1c	4.92	4.92	4.92	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100065	NA	LumB	IBD	PID	ICR2	HER2+	400003317	NUH.BT095	DistantMetastasisFree	0.42	DiseaseFree	DistantMetastasisFree	44	LN+	ER+	PR+	G2	2.4	T2	0.42	0.42	0.42	0	no	no	0	invasive ductal carcinoma	none
GSM1100066	NA	LumB	IBD	WID	ICR3	HER2+	400003318	NUH.BT096	DistantMetastasis	1.67	Recurred/Progressed	DistantMetastasis	46	LN+	ER+	PR-	G2	6	T3/T4	1.67	1.67	1.75	1	yes	yes	1	invasive ductal carcinoma	Tam+CAFx2 cycles
GSM1100067	NA	LumB	IBD	WID	ICR3	HER2-	400003319	NUH.BT097	DistantMetastasisFree	4.5	DiseaseFree	DistantMetastasisFree	42	LN+	ER+	PR-	G2	3	T2	4.5	4.5	4.5	NA	NA	NA	0	invasive ductal carcinoma	NA
GSM1100068	NA	LumA	IBD	PID	ICR1	HER2-	400003320	NUH.BT103	DistantMetastasisFree	4.88	DiseaseFree	DistantMetastasisFree	46	LN-	ER+	PR+	G2	1.5	T1c	4.88	4.88	4.88	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100069	NA	Her2	IBD	PID	ICR1	HER2-	400003321	NUH.BT104	DistantMetastasisFree	4.83	DiseaseFree	DistantMetastasisFree	73	LN+	ER+	PR+	G2	2	T1c	4.83	4.83	4.92	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100070	NA	LumB	IBD	PID	ICR1	HER2-	400003322	NUH.BT108	DistantMetastasisFree	4	DiseaseFree	DistantMetastasisFree	46	LN+	ER-	PR+	G2	4	T2	4	4	4.5	NA	NA	NA	0	invasive ductal and lobular carcinoma	NA
GSM1100071	NA	NA	NA	NA	NA	HER2+	400003323	NUH.BT111	NA	NA	NA	NA	66	LN-	ER+	PR+	G2	1.7	T1c	NA	NA	0.08	NA	NA	NA	0	invasive ductal carcinoma	NA
GSM1100072	NA	LumB	IBD	WID	ICR1	HER2-	400003324	NUH.BT113	DistantMetastasisFree	5.58	DiseaseFree	DistantMetastasisFree	64	LN-	ER+	PR+	G2	1.2	T1c	5.58	5.58	5.58	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100073	NA	LumA	IBD	WID	ICR3	HER2-	400003325	NUH.BT114	DistantMetastasisFree	5.33	DiseaseFree	DistantMetastasisFree	49	LN-	ER+	PR+	G2	1.5	T1c	5.33	5.33	5.33	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100074	NA	ClaudinLow	IBD	PID	ICR1	HER2-	400003326	NUH.BT119	DistantMetastasisFree	5	DiseaseFree	DistantMetastasisFree	47	LN-	ER+	PR+	G2	3.5	T2	5	5	5	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100075	NA	Basal	IBD	PID	ICR1	HER2+	400003327	NUH.BT001	DistantMetastasisFree	1.54	DiseaseFree	DistantMetastasisFree	34	LN-	ER-	PR-	G3	4	T2	1.54	1.54	5.46	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100076	NA	Normal	IBE	NA	ICR2	HER2-	400003328	NUH.BT010	DistantMetastasisFree	5.46	DiseaseFree	DistantMetastasisFree	45	LN-	ER+	PR+	G1	1.5	T1c	5.46	5.46	5.46	1	yes	no	0	invasive ductal carcinoma	tamoxifen;goserelin
GSM1100077	NA	LumA	IBD	WID	ICR4	HER2+	400003329	NUH.BT100	DistantMetastasisFree	4.46	DiseaseFree	DistantMetastasisFree	55	LN-	ER+	PR+	G3	2	T1c	4.46	4.46	4.46	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100078	NA	LumA	IBD	WID	ICR3	HER2-	400003330	NUH.BT101	DistantMetastasisFree	4.88	DiseaseFree	DistantMetastasisFree	47	LN+	ER+	PR+	G3	3.2	T2	4.88	4.88	4.88	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100079	NA	Basal	IBD	PID	ICR1	HER2-	400003331	NUH.BT102	DistantMetastasisFree	0.13	DiseaseFree	DistantMetastasisFree	66	LN-	ER+	PR+	G1	3.8	T2	NA	0.13	0.13	1	yes	no	0	mucinous carcinoma	tamoxifen
GSM1100080	NA	LumA	IBD	PID	ICR2	HER2+	400003332	NUH.BT107	DistantMetastasisFree	1	DiseaseFree	DistantMetastasisFree	55	LN-	ER-	PR-	G3	6	T3/T4	1	1	5	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100081	NA	LumA	IBD	WID	ICR3	HER2+	400003333	NUH.BT110	DistantMetastasisFree	4	DiseaseFree	DistantMetastasisFree	52	LN+	ER-	PR-	G3	3.5	T2	4	4	4.33	1	no	yes	0	invasive lobular carcinoma	ACx4 cycles
GSM1100082	NA	Basal	IBE	PID	ICR2	HER2+	400003334	NUH.BT112	DistantMetastasis	2.04	Recurred/Progressed	DistantMetastasis	74	LN+	ER+	PR-	G3	3	T2	2.04	2.04	2.25	1	yes	no	1	invasive ductal carcinoma	tamoxifen
GSM1100083	NA	Basal	IBE	PID	ICR2	NA	400003335	NUH.BT117	DistantMetastasisFree	4	DiseaseFree	DistantMetastasisFree	44	LN+	ER-	PR-	G3	5	T2	4	4	4	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100084	NA	Her2	IBE	FID	ICR3	HER2+	400003336	NUH.BT012	DistantMetastasis	3.96	Recurred/Progressed	DistantMetastasis	54	LN+	ER-	PR-	G3	2	T1c	3.96	3.96	4.63	1	no	yes	1	invasive ductal carcinoma	ACx4 cycles
GSM1100085	NA	LumA	IBD	WID	ICR2	HER2+	400003337	NUH.BT120	DistantMetastasisFree	5.25	DiseaseFree	DistantMetastasisFree	45	LN+	ER+	PR+	G3	2.5	T2	5.25	5.25	5.29	1	no	yes	0	invasive ductal carcinoma	AC
GSM1100086	NA	LumA	IBD	WID	ICR3	HER2+	400003338	NUH.BT013	DistantMetastasisFree	1.96	DiseaseFree	DistantMetastasisFree	58	LN+	ER+	PR+	G3	3	T2	1.96	1.96	1.96	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100087	NA	ClaudinLow	IBD	WID	ICR3	HER2+	400003339	NUH.BT015	DistantMetastasis	0.001	Recurred/Progressed	DistantMetastasis	62	LN+	ER+	PR+	G3	2.5	T2	0	0	2.08	1	yes	yes	1	invasive ductal carcinoma	Arimidex+CMFx2 cycles
GSM1100088	NA	Her2	IBD	PID	ICR1	HER2+	400003340	NUH.BT016	DistantMetastasis	0.88	Recurred/Progressed	DistantMetastasis	62	LN+	ER-	PR-	G3	3.5	T2	0.88	0.88	1	0	no	no	0	invasive ductal carcinoma	none
GSM1100089	NA	Normal	IBE	NA	ICR3	HER2+	400003341	NUH.BT017	DistantMetastasisFree	5.08	DiseaseFree	DistantMetastasisFree	64	LN-	ER-	PR-	G3	3	T2	5.08	5.08	5.08	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100090	NA	Normal	IBE	NA	ICR4	HER2+	400003342	NUH.BT002	DistantMetastasisFree	4.83	DiseaseFree	DistantMetastasisFree	45	LN+	ER-	PR-	G3	2	T1c	4.83	4.83	4.83	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100091	NA	LumA	IBD	WID	ICR2	HER2-	400003343	NUH.BT020	DistantMetastasis	1.96	Recurred/Progressed	DistantMetastasis	80	LN+	ER+	PR+	G3	4	T2	1.96	1.96	1.96	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100092	NA	LumA	IBD	FID	ICR4	HER2-	400003344	NUH.BT003	DistantMetastasisFree	5.54	DiseaseFree	DistantMetastasisFree	41	LN-	ER-	PR-	G3	4	T2	5.54	5.54	5.54	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100093	NA	LumB	IBE	PID	ICR1	HER2+	400003345	NUH.BT033	DistantMetastasis	0.13	Recurred/Progressed	DistantMetastasis	46	LN+	ER-	PR-	G3	2.2	T2	0.13	0.13	0.38	NA	NA	NA	1	invasive ductal carcinoma	NA
GSM1100094	NA	LumA	IBD	FID	ICR3	HER2+	400003346	NUH.BT034	DistantMetastasis	1.29	Recurred/Progressed	DistantMetastasis	54	LN+	ER-	PR-	G3	3.5	T2	1.29	1.29	1.38	1	no	yes	1	invasive ductal carcinoma	CAF
GSM1100095	NA	LumB	IBD	PID	ICR1	HER2-	400003347	NUH.BT036	DistantMetastasisFree	3.13	DiseaseFree	DistantMetastasisFree	86	LN+	ER+	PR+	G1	2.1	T2	3.13	3.13	4.38	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100096	NA	ClaudinLow	IBD	FID	ICR4	HER2-	400003348	NUH.BT037	DistantMetastasis	2.21	Recurred/Progressed	DistantMetastasis	29	LN+	ER+	PR+	G1	8	T3/T4	2.21	2.21	3.04	1	no	yes	1	invasive lobular carcinoma	CAFx6 cycles
GSM1100097	NA	LumB	IBD	PID	ICR3	HER2+	400003349	NUH.BT038	DistantMetastasisFree	4.38	DiseaseFree	DistantMetastasisFree	34	LN+	ER+	PR+	G3	3.5	T2	4.38	4.38	4.38	1	no	yes	0	invasive ductal carcinoma	ACx8 cycles; taxol
GSM1100098	NA	LumB	IBE	PID	ICR3	HER2-	400003350	NUH.BT039	DistantMetastasisFree	5.08	DiseaseFree	DistantMetastasisFree	48	LN+	ER-	PR-	G3	3	T2	5.08	5.08	5.08	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100099	NA	LumA	IBD	WID	ICR3	HER2-	400003351	NUH.BT004	DistantMetastasisFree	4.17	DiseaseFree	DistantMetastasisFree	42	LN-	ER-	PR-	G3	2.2	T2	4.17	4.17	4.25	1	no	yes	0	invasive ductal carcinoma	AC
GSM1100100	NA	Her2	IBD	WID	ICR2	HER2-	400003352	NUH.BT040	DistantMetastasisFree	0.75	DiseaseFree	DistantMetastasisFree	48	LN-	ER-	PR-	G3	3.5	T2	0.75	0.75	0.75	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100101	NA	LumB	IBD	PID	ICR1	HER2+	400003353	NUH.BT041	DistantMetastasisFree	6.29	DiseaseFree	DistantMetastasisFree	52	LN+	ER+	PR+	G3	4.5	T2	6.29	6.29	6.29	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100102	NA	Normal	IBE	NA	ICR1	HER2-	400003354	NUH.BT043	DistantMetastasisFree	5.58	DiseaseFree	DistantMetastasisFree	60	LN-	ER+	PR+	G1	1.5	T1c	5.58	5.58	5.79	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100103	NA	LumB	IBE	PID	ICR1	HER2+	400003355	NUH.BT045	DistantMetastasis	0.79	Recurred/Progressed	DistantMetastasis	51	LN+	ER-	PR-	G3	3	T2	0.79	0.79	1.46	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100104	NA	LumA	IBD	WID	ICR2	HER2+	400003356	NUH.BT048	DistantMetastasis	2.29	Recurred/Progressed	DistantMetastasis	38	LN-	ER+	PR-	G3	3.6	T2	2.29	2.29	2.88	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100105	NA	LumA	IBD	FID	ICR4	HER2+	400003357	NUH.BT005	DistantMetastasisFree	4	DiseaseFree	DistantMetastasisFree	42	LN-	ER-	PR-	G3	2.3	T2	4	4	4	NA	NA	NA	0	invasive ductal carcinoma	NA
GSM1100106	NA	NA	NA	NA	NA	HER2-	400003358	NUH.BT050	NA	NA	NA	NA	81	LN-	ER+	PR+	G1	4	T2	NA	NA	NA	1	yes	no	NA	papillary carcinoma	tamoxifen
GSM1100107	NA	LumA	IBD	WID	ICR2	HER2-	400003359	NUH.BT051	DistantMetastasisFree	3.5	DiseaseFree	DistantMetastasisFree	77	LN-	ER+	PR+	G1	4	T2	3.5	3.5	4.33	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100108	NA	Normal	IBE	NA	ICR3	HER2-	400003360	NUH.BT052	DistantMetastasisFree	1.17	DiseaseFree	DistantMetastasisFree	42	LN-	ER-	PR-	G3	2	T1c	1.17	1.17	6.5	0	no	no	0	medullary carcinoma	none
GSM1100109	NA	LumA	IBD	PID	ICR1	HER2-	400003361	NUH.BT053	DistantMetastasisFree	5.88	DiseaseFree	DistantMetastasisFree	61	LN+	ER+	PR-	G3	2.5	T2	5.88	5.88	5.88	1	no	yes	0	invasive ductal carcinoma	CMF
GSM1100110	NA	LumA	IBD	PID	ICR1	HER2+	400003362	NUH.BT056	DistantMetastasisFree	5.71	DiseaseFree	DistantMetastasisFree	48	LN-	ER-	PR-	G3	3.2	T2	5.71	5.71	5.71	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100111	NA	Basal	IBD	FID	ICR3	HER2+	400003363	NUH.BT059	DistantMetastasisFree	5.83	DiseaseFree	DistantMetastasisFree	61	LN+	ER-	PR-	G3	1.5	T1c	5.83	5.83	5.83	1	no	yes	0	invasive ductal carcinoma	CAFx6 cycles
GSM1100112	NA	LumA	IBD	FID	ICR3	HER2-	400003364	NUH.BT006	DistantMetastasisFree	6.17	DiseaseFree	DistantMetastasisFree	36	LN-	ER+	PR+	G3	2.5	T2	6.17	6.17	6.17	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100113	NA	Basal	IBE	PID	ICR1	HER2+	400003365	NUH.BT060	DistantMetastasisFree	1.33	Recurred/Progressed	DistantMetastasisFree	51	LN-	ER-	PR-	G3	2.7	T2	1.92	1.33	5.58	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100114	NA	LumB	IBE	WID	ICR3	HER2-	400003366	NUH.BT062	DistantMetastasisFree	5.83	DiseaseFree	DistantMetastasisFree	46	LN-	ER-	PR-	G3	2.5	T2	5.83	5.83	5.83	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100115	NA	Her2	IBE	WID	ICR4	HER2+	400003367	NUH.BT063	DistantMetastasisFree	5.83	DiseaseFree	DistantMetastasisFree	48	LN-	ER-	PR-	G3	3.5	T2	5.83	5.83	5.83	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100116	NA	Basal	IBE	PID	ICR2	HER2-	400003368	NUH.BT064	DistantMetastasisFree	5.79	DiseaseFree	DistantMetastasisFree	51	LN-	ER+	PR-	G3	1.8	T1c	5.79	5.79	5.79	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100117	NA	Her2	IBD	PID	ICR2	HER2+	400003369	NUH.BT065	DistantMetastasisFree	5.88	DiseaseFree	DistantMetastasisFree	47	LN-	ER-	PR-	G3	2.1	T2	5.88	5.88	5.88	1	no	yes	0	invasive ductal carcinoma	ACx4 cycles
GSM1100118	NA	LumA	IBD	PID	ICR2	HER2+	400003370	NUH.BT066	DistantMetastasisFree	5.92	DiseaseFree	DistantMetastasisFree	58	LN+	ER+	PR+	G3	5.1	T3/T4	5.92	5.92	5.92	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100119	NA	LumA	IBD	WID	ICR3	HER2+	400003371	NUH.BT007	DistantMetastasisFree	5.58	DiseaseFree	DistantMetastasisFree	38	LN-	ER+	PR+	G3	3.8	T2	5.58	5.58	5.58	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100120	NA	Basal	IBE	PID	ICR1	HER2-	400003372	NUH.BT071	DistantMetastasisFree	4.54	DiseaseFree	DistantMetastasisFree	47	LN+	ER+	PR+	G3	3	T2	4.54	4.54	4.54	1	no	yes	0	invasive ductal carcinoma	CAF
GSM1100121	NA	Basal	IBE	FID	ICR4	HER2+	400003373	NUH.BT072	DistantMetastasisFree	5.21	DiseaseFree	DistantMetastasisFree	64	LN-	ER+	PR+	G3	5	T2	5.21	5.21	5.21	1	yes	no	0	medullary carcinoma	tamoxifen
GSM1100122	NA	Her2	IBE	WID	ICR2	HER2+	400003374	NUH.BT073	DistantMetastasis	3.83	Recurred/Progressed	DistantMetastasis	50	LN+	ER-	PR+	G3	1.6	T1c	3.83	3.83	5.75	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100123	NA	Her2	IBD	FID	ICR3	HER2-	400003375	NUH.BT076	DistantMetastasisFree	5.17	DiseaseFree	DistantMetastasisFree	52	LN-	ER+	PR+	G1	2	T1c	5.17	5.17	5.17	1	yes	no	0	invasive lobular carcinoma	tamoxifen
GSM1100124	NA	LumB	IBE	WID	ICR3	HER2+	400003376	NUH.BT077	DistantMetastasisFree	4.92	DiseaseFree	DistantMetastasisFree	67	LN+	ER+	PR-	G3	2.5	T2	4.92	4.92	4.92	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100125	NA	Normal	IBE	NA	ICR3	HER2+	400003377	NUH.BT008	DistantMetastasis	2	Recurred/Progressed	DistantMetastasis	38	LN+	ER+	PR+	G3	4	T2	2	2	2	1	yes	yes	0	invasive ductal carcinoma	Tam+AC
GSM1100126	NA	LumB	IBE	PID	ICR3	HER2-	400003378	NUH.BT082	DistantMetastasisFree	0.83	DiseaseFree	DistantMetastasisFree	84	LN-	ER+	PR+	G3	2.8	T2	0.83	0.83	0.83	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100127	NA	Normal	IBE	NA	ICR2	NA	400003379	NUH.BT084	DistantMetastasisFree	4.67	DiseaseFree	DistantMetastasisFree	55	LN-	NA	NA	G1	2.5	T2	4.67	4.67	4.67	0	no	no	0	invasive ductal carcinoma and papillary carcinoma	none
GSM1100128	NA	ClaudinLow	IBD	WID	ICR2	HER2-	400003380	NUH.BT089	DistantMetastasisFree	2.67	DiseaseFree	DistantMetastasisFree	43	LN+	ER+	PR+	G1	2.4	T2	2.67	2.67	2.67	1	yes	yes	0	invasive ductal carcinoma	Tam+ACx4 cycles
GSM1100129	NA	LumB	IBD	WID	ICR2	HER2-	400003381	NUH.BT091	DistantMetastasisFree	4.38	DiseaseFree	DistantMetastasisFree	62	LN-	ER+	PR+	G3	2	T1c	4.38	4.38	4.38	1	yes	no	0	invasive ductal carcinoma	tamoxifen
GSM1100130	NA	Her2	IBD	PID	ICR1	HER2-	400003382	NUH.BT092	DistantMetastasisFree	4.83	DiseaseFree	DistantMetastasisFree	59	LN+	ER+	PR+	G1	6	T3/T4	4.83	4.83	4.83	NA	NA	NA	0	invasive ductal carcinoma	NA
GSM1100131	NA	LumB	IBD	PID	ICR1	NA	400003383	NUH.BT099	DistantMetastasisFree	4.33	DiseaseFree	DistantMetastasisFree	53	LN+	ER+	PR+	G3	3.5	T2	4.33	4.33	4.33	1	yes	yes	0	invasive ductal carcinoma	Tam+CMFx6 cycles
GSM1100132	NA	Her2	IBD	PID	ICR1	HER2+	400003384	95_1279	DistantMetastasis	3.05	NA	DistantMetastasis	63	LN-	ER+	NA	G2	3	T2	NA	3.05	3.449315068	1	yes	no	1	NA	Tamoxifen
GSM1100133	NA	Her2	IBE	PID	ICR3	HER2+	400003385	95_9670	DistantMetastasis	1.39	NA	DistantMetastasis	47	LN-	ER+	PR+	G3	2.8	T2	NA	1.39	2.126027397	1	yes	yes	1	NA	CMFx6; Tamoxifen
GSM1100134	NA	Her2	IBE	FID	ICR3	HER2+	400003386	96_6784	DistantMetastasis	0.65	NA	DistantMetastasis	59	LN-	ER-	PR-	G3	2.5	T2	NA	0.65	3.079452055	1	yes	no	1	NA	Tamoxifen
GSM1100135	NA	LumB	IBE	PID	ICR2	HER2-	400003387	96_8645	DistantMetastasis	4.18	NA	DistantMetastasis	66	LN-	ER-	PR-	G3	2.1	T2	NA	4.18	4.194520548	1	yes	no	1	NA	Tamoxifen
GSM1100136	NA	LumB	IBD	PID	ICR1	HER2-	400003388	97_4970	DistantMetastasis	4.51	NA	DistantMetastasis	68	LN-	ER+	PR+	G3	1.7	T1c	NA	4.51	6.17260274	1	yes	no	1	NA	Tamoxifen
GSM1100137	NA	Her2	IBD	FID	ICR4	HER2+	400003389	97_2461	DistantMetastasis	0.25	NA	DistantMetastasis	57	LN-	ER+	PR+	NA	8.5	T3/T4	NA	0.25	5.035616438	1	yes	no	1	NA	Tamoxifen
GSM1100138	NA	LumB	IBE	PID	ICR1	HER2-	400003390	97_6230	DistantMetastasis	1.35	NA	DistantMetastasis	38	LN-	ER+	PR-	G3	3.2	T2	NA	1.35	2.753424658	1	yes	yes	1	NA	ECx4; Tamoxifen
GSM1100139	NA	LumB	IBE	PID	ICR1	HER2-	400003391	97_10495	DistantMetastasis	2.21	NA	DistantMetastasis	63	LN-	ER+	PR+	G3	4.6	T2	NA	2.21	4.928767123	1	yes	no	1	NA	Tamoxifen
GSM1100140	NA	Basal	IBE	PID	ICR2	HER2-	400003392	98_1467	DistantMetastasis	3.8	NA	DistantMetastasis	73	LN-	ER-	PR-	G3	3.4	T2	NA	3.8	4.621917808	1	no	yes	1	NA	ACx3/CMFx1
GSM1100141	NA	LumB	IBE	PID	ICR1	HER2+	400003393	00_4773	DistantMetastasis	0.76	NA	DistantMetastasis	70	LN-	ER+	PR+	G3	3.5	T2	NA	0.76	0.991780822	1	yes	no	1	NA	Tamoxifen
GSM1100142	NA	LumA	IBD	WID	ICR3	HER2-	400003394	97_3659	DistantMetastasisFree	2.18	NA	DistantMetastasisFree	46	LN-	ER+	PR-	G1	1	T1b	NA	2.18	2.189041096	1	yes	yes	0	NA	Tamoxifen+Zoledronic acid
GSM1100143	NA	LumB	IBD	PID	ICR2	HER2-	400003395	95_5655	DistantMetastasis	2.42	NA	DistantMetastasis	36	LN-	ER-	PR-	G2	1.3	T1c	NA	2.42	7.079452055	1	yes	yes	0	NA	Tamoxifen+Zoledronic acid
GSM1100144	NA	LumA	IBD	WID	ICR2	HER2-	400003396	96_1378	DistantMetastasis	6.15	NA	DistantMetastasis	54	LN-	ER+	PR-	G1	5.5	T3/T4	NA	6.15	8.021917808	1	no	yes	0	NA	ACx4
GSM1100145	NA	LumB	IBD	WID	ICR3	HER2-	400003397	97_2927	DistantMetastasis	3.65	NA	DistantMetastasis	60	LN-	ER+	PR+	G3	4	T2	NA	3.65	6.750684932	1	yes	yes	0	NA	CMFx2; Tamoxifen
GSM1100146	NA	LumB	IBD	WID	ICR2	HER2+	400003398	98_478	DistantMetastasis	3.3	NA	DistantMetastasis	72	LN-	ER+	PR+	G3	3.7	T2	NA	3.3	5.164383562	1	yes	no	0	NA	Arimidex/Tamoxifen
GSM1100147	NA	LumB	IBE	FID	ICR4	HER2-	400003399	95_5029	DistantMetastasisFree	7.82	NA	DistantMetastasisFree	54	LN-	ER-	PR-	G2	1	T1b	NA	7.82	7.821917808	1	yes	no	0	NA	Tamoxifen
GSM1100148	NA	Her2	IBE	PID	ICR3	HER2+	400003400	94_14421	DistantMetastasisFree	7.85	NA	DistantMetastasisFree	48	LN-	ER+	NA	G2	1.2	T1c	NA	7.85	7.854794521	1	yes	yes	0	NA	Tamoxifen+Zoledronic acid
GSM1100149	NA	LumB	IBD	WID	ICR3	HER2-	400003401	95_6413	DistantMetastasisFree	7.31	NA	DistantMetastasisFree	55	LN-	ER+	PR+	G3	1.8	T1c	NA	7.31	7.306849315	1	yes	no	0	NA	Tamoxifen
GSM1100150	NA	Her2	IBD	PID	ICR1	HER2+	400003402	95_11893	DistantMetastasisFree	7.57	NA	DistantMetastasisFree	81	LN-	ER+	PR-	G2	2	T1c	NA	7.57	7.57260274	1	yes	no	0	NA	Tamoxifen
GSM1100151	NA	Normal	IBE	NA	ICR2	HER2+	400003403	96_4793	DistantMetastasisFree	6.02	NA	DistantMetastasisFree	52	LN-	ER-	PR-	G2	2	T1c	NA	6.02	6.019178082	1	yes	yes	0	NA	ACx4; Tamoxifen
GSM1100152	NA	LumA	IBD	PID	ICR1	HER2+	400003404	97_938	DistantMetastasisFree	6.18	NA	DistantMetastasisFree	77	LN-	ER+	PR+	G2	1.5	T1c	NA	6.18	6.175342466	1	yes	no	0	NA	Tamoxifen
GSM1100153	NA	LumB	IBD	WID	ICR3	HER2+	400003405	96_3800	DistantMetastasisFree	6.65	NA	DistantMetastasisFree	70	LN-	ER+	PR-	G2	3.5	T2	NA	6.65	6.652054795	1	yes	no	0	NA	Tamoxifen
GSM1100154	NA	Basal	IBE	WID	ICR3	HER2-	400003406	96_2614	DistantMetastasisFree	6.61	NA	DistantMetastasisFree	67	LN-	ER-	PR-	G3	4	T2	NA	6.61	6.61369863	1	yes	yes	0	NA	ACx6; Tamoxifen
GSM1100155	NA	Her2	IBE	WID	ICR3	HER2+	400003407	96_3132	DistantMetastasisFree	6.13	NA	DistantMetastasisFree	62	LN-	ER+	PR+	G3	2.7	T2	NA	6.13	6.128767123	1	yes	no	0	NA	Tamoxifen
GSM1100156	NA	LumA	IBD	PID	ICR1	HER2-	400003408	96_8234	DistantMetastasisFree	5.94	NA	DistantMetastasisFree	66	LN-	ER+	PR+	G1	2.7	T2	NA	5.94	5.936986301	1	yes	no	0	NA	Tamoxifen
GSM1100157	NA	LumA	IBD	PID	ICR1	HER2+	400003409	96_14641	DistantMetastasisFree	3.12	NA	DistantMetastasisFree	57	LN-	ER+	PR-	G1	2	T1c	NA	3.12	3.115068493	1	yes	no	0	NA	Tamoxifen
GSM1100158	NA	LumB	IBE	WID	ICR3	NA	400003410	96_9210	DistantMetastasisFree	2.57	NA	DistantMetastasisFree	46	LN-	NA	NA	G3	3.2	T2	NA	2.57	2.57260274	1	yes	yes	0	NA	CMFx6; Tamoxifen
GSM1100159	NA	ClaudinLow	IBD	PID	ICR1	HER2-	400003411	96_12695	DistantMetastasisFree	6.19	NA	DistantMetastasisFree	73	LN-	ER-	PR-	NA	3.8	T2	NA	6.19	6.18630137	NA	NA	NA	0	NA	NA
GSM1100160	NA	LumA	IBD	WID	ICR2	HER2-	400003412	97_1564	DistantMetastasisFree	6.69	NA	DistantMetastasisFree	42	LN-	ER+	PR+	G2	1.4	T1c	NA	6.69	6.693150685	1	no	yes	0	NA	CMFx6
GSM1100161	NA	LumB	IBE	FID	ICR4	HER2-	400003413	97_3340	DistantMetastasisFree	5.52	NA	DistantMetastasisFree	53	LN-	ER+	PR+	G3	1.9	T1c	NA	5.52	5.523287671	1	yes	no	0	NA	Tamoxifen
GSM1100162	NA	LumA	IBD	PID	ICR1	HER2-	400003414	97_5410	DistantMetastasisFree	5.11	NA	DistantMetastasisFree	60	LN-	ER+	PR+	G3	2	T1c	NA	5.11	5.109589041	1	yes	yes	0	NA	ACx4; Arimidex/Tamoxifen
GSM1100163	NA	Basal	IBE	WID	ICR3	HER2-	400003415	97_7954	DistantMetastasisFree	5.57	NA	DistantMetastasisFree	61	LN-	ER-	PR-	G3	1.4	T1c	NA	5.57	5.567123288	1	yes	yes	0	NA	CMFx6; Arimidex/Tamoxifen
GSM1100164	NA	Her2	IBE	FID	ICR3	NA	400003416	97_10321	DistantMetastasisFree	6.26	NA	DistantMetastasisFree	59	LN-	ER-	PR-	G3	4.5	T2	NA	6.26	6.257534247	1	no	yes	0	NA	ACx4
GSM1100165	NA	LumB	IBD	PID	ICR1	HER2-	400003417	97_10569	DistantMetastasisFree	5.13	NA	DistantMetastasisFree	70	LN-	ER+	PR-	G2	2	T1c	NA	5.13	5.134246575	1	yes	no	0	NA	Tamoxifen
GSM1100166	NA	LumA	IBD	PID	ICR2	HER2-	400003418	97_9201	DistantMetastasisFree	4.64	NA	DistantMetastasisFree	45	LN-	ER+	PR+	G2	2	T1c	NA	4.64	4.643835616	1	no	yes	0	NA	CMFx6
GSM1100167	NA	Basal	IBE	PID	ICR2	HER2+	400003419	98_176	DistantMetastasisFree	5.01	NA	DistantMetastasisFree	48	LN-	ER-	PR-	G3	6	T3/T4	NA	5.01	5.008219178	1	no	yes	0	NA	CMFx6
GSM1100168	NA	LumA	IBD	PID	ICR2	HER2+	400003420	97_12101	DistantMetastasisFree	4.56	NA	DistantMetastasisFree	45	LN-	ER+	PR+	G2	3	T2	NA	4.56	4.561643836	1	yes	no	0	NA	Tamoxifen
GSM1100169	NA	Basal	IBE	FID	ICR4	HER2-	400003421	98_301	DistantMetastasisFree	4.96	NA	DistantMetastasisFree	46	LN-	ER-	PR-	G3	2.7	T2	NA	4.96	4.95890411	1	yes	yes	0	NA	CMFx6; Tamoxifen
GSM1100170	NA	LumA	IBD	WID	ICR2	HER2+	400003422	98_8377	DistantMetastasisFree	3.93	NA	DistantMetastasisFree	56	LN-	ER+	PR+	G1	3	T2	NA	3.93	3.926027397	1	yes	no	0	NA	Tamoxifen
GSM1100171	NA	LumB	IBD	FID	ICR4	HER2-	400003423	98_2095	DistantMetastasisFree	4.51	NA	DistantMetastasisFree	72	LN-	ER+	PR-	G2	2	T1c	NA	4.51	4.509589041	1	yes	no	0	NA	Tamoxifen
GSM1100172	NA	ClaudinLow	IBD	FID	ICR3	HER2-	400003424	01_1620	DistantMetastasisFree	1.66	NA	DistantMetastasisFree	50	LN-	ER-	PR-	G3	2.9	T2	NA	1.66	1.660273973	1	no	yes	0	NA	CMFx6
GSM1100173	NA	ClaudinLow	IBD	FID	ICR3	NA	400003425	OXFU_369	DistantMetastasis	7.15	Recurred/Progressed	DistantMetastasis	67	LN-	ER-	NA	NA	1	T1b	7.15	7.151	NA	0	no	no	NA	NA	none
GSM1100174	NA	ClaudinLow	IBD	FID	ICR3	NA	400003426	OXFU_410	DistantMetastasisFree	10	Recurred/Progressed	DistantMetastasisFree	37	LN-	ER-	NA	G2	2.3	T2	10.61	10.614	NA	0	no	no	NA	NA	none
GSM1100175	NA	ClaudinLow	IBD	FID	ICR3	NA	400003427	OXFU_554	DistantMetastasisFree	9.42	DiseaseFree	DistantMetastasisFree	43	LN-	ER+	NA	G1	2.1	T2	9.42	9.419	NA	0	no	no	NA	NA	none

Group Sets View in Gene Expression Browser

Name
All Samples	Default	View
ER Status		View
Histology Differentiation Grade		View
Immune Benefit Status		View
Immunological Constant of Rejection		View
Lymph Node Status		View
Molecular Subtype		View
Pathology T Stage		View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set
All Samples
ER Status
Histology Differentiation Grade
Immune Benefit Status
Immunological Constant of Rejection
Lymph Node Status
Molecular Subtype
Pathology T Stage

SIDRA